Atossa Therapeutics
ATOS
#9237
Rank
โ‚น9.27 B
Marketcap
โ‚น71.81
Share price
5.24%
Change (1 day)
-29.34%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -โ‚น2.45 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น2.3 Billion, an increase over its 2023 earnings that were of -โ‚น2.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.45 Billion6.79%
2024 -โ‚น2.3 Billion-15.25%
2023 -โ‚น2.71 Billion11.62%
2022 -โ‚น2.43 Billion30.84%
2021 -โ‚น1.86 Billion15.58%
2020 -โ‚น1.61 Billion3.41%
2019 -โ‚น1.55 Billion51.16%
2018 -โ‚น1.03 Billion40.41%
2017 -โ‚น0.73 Billion27.54%
2016 -โ‚น0.58 Billion-47.49%
2015 -โ‚น1.09 Billion-17.25%
2014 -โ‚น1.32 Billion35.91%
2013 -โ‚น0.97 Billion112.3%
2012 -โ‚น0.46 Billion46.53%
2011 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.910 T-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น119.76 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น115.61 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น0.71 Billion-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น3.74 B-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น9.82 Billion 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA